Use of Active Surveillance vs Definitive Treatment Among Men With Low- and Favorable Intermediate–Risk Prostate Cancer in the US Between 2010 and 2018
Watchful waiting
DOI:
10.1001/jamainternmed.2022.7100
Publication Date:
2023-04-03T15:01:25Z
AUTHORS (7)
ABSTRACT
This cross-sectional study of data from the Surveillance, Epidemiology and End Results database assesses temporal trends in use active surveillance watchful waiting vs definitive treatment men with low- favorable intermediate–risk prostate cancer US between 2010 2018.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (6)
CITATIONS (11)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....